Related Experiment Videos
Treatment of hairy cell leukemia patients with 2-chloro-2'-deoxyadenosine (2-CdA)
M Komarnicki1, M Kaźmierczak, J Hansz
1Department of Hematology, Medical Academy, Poznań, Poland.
Archivum Immunologiae Et Therapiae Experimentalis
|January 1, 1994
Abstract:
A preliminary study of six hairy cell leukemia patients treated with one course of 2-chloro-2'-deoxyadenosine (2-CdA) is presented. 2-CdA was administered 0.1 mg/kg/daily by intravenous infusion over 7 days. Two patients achieved CR and four PR.